32
Views
0
CrossRef citations to date
0
Altmetric
Papers

Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus

, , , , , & show all
Pages 57-70 | Received 30 Apr 2008, Published online: 10 Jul 2009

References

  • Allsopp TE, Fazakerley JK. Altruistic cell suicide and the specialized case of the virus-infected nervous system. Trends Neurosci 2000; 23: 284–290
  • Atasheva S, Gorchakov R, English R, Frolov I, Frolova E. Development of Sindbis viruses encoding nsP2/GFP chimeric proteins and their application for studying nsP2 functioning. J Virol 2007; 81: 5046–5057
  • Atkins GJ, Sheahan BJ, Liljestrom P. The molecular pathogenesis of Semliki Forest virus: a model virus made useful. J. Gen. Virol. 1999; 80: 2287–2297
  • Balluz IM, Glasgow GM, Killen HM, Mabruk MJ, Sheahan BJ, Atkins GJ. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathol. Appl Neurobiol 1993; 19: 233–239
  • Bradish CJ, Allner K, Maber HB. The virulence of original and derived strains of Semliki Forest virus for mice, guinea-pigs and rabbits. J. Gen Virol. 1971; 12: 141–160
  • Del Piero F, Wilkins PA, Dubovi EJ, Biolatti B, Cantile C. Clinical, pathologic, immunohistochemical, and virologic findings of eastern equine encephalomyelitis in two horses. Vet Pathol 2001; 38: 451–456
  • Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip.’. J Gen Virol. 2001; 82: 1013–1025
  • Fazakerley JK. Pathogenesis of Semliki Forest virus encephalitis. J NeuroVirol. 2002; 8(Suppl 2)66–74
  • Fazakerley JK, Boyd A, Mikkola ML, Kaariainen L. A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus. J Virol. 2002; 76: 392–396
  • Fazakerley JK, Cotterill CL, Lee G, Graham A. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions. Neuropathol. Appl Neurobiol 2006; 32: 397–409
  • Fazakerley JK, Pathak S, Scallan M, Amor S, Dyson H. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 1993; 195: 627–637
  • Fragkoudis R, Breakwell L, McKimmie C, Boyd A, Barry G, Kohl A, Merits A, Fazakerley JK. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons. J Gen Virol. 2007; 88: 3373–3384
  • Frolov I, Hoffman TA, Pragai BM, Dryga SA, Huang HV, Schlesinger S, Rice CM. Alphavirus-based expression vectors: strategies and applications. Proc Natl. Acad Sci. U S A 1996; 93: 11371–11377
  • Frolova E, Gorchakov R, Garmashova N, Atasheva S, Vergara LA, Frolov I. Formation of nsP3-specific protein complexes during Sindbis virus replication. J Virol 2006; 80: 4122–4134
  • Gates MC, Sheahan BJ, O'Sullivan MA, Atkins GJ. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures. J Gen Virol 1985; 66( Pt 11): 2365–2373
  • Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, Liljestrom P. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology 1991; 185: 741–748
  • Griffin DE. Neuronal cell death in alphavirus encephalomyelitis. Curr Top Microbiol Immunol. 2005; 289: 57–77
  • Kiiver K, Tagen I, Zusinaite E, Tamberg N, Fazakerley JK, Merits A. Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication. J Gen Virol. 2008; 89: 1457–1466
  • Kujala P, Ikaheimonen A, Ehsani N, Vihinen H, Auvinen P, Kaariainen L. Biogenesis of the Semliki Forest virus RNA replication complex. J Virol. 2001; 75: 3873–3884
  • Lemm JA, Rice CM. Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34. J Virol. 1993; 67: 1905–1915
  • Liebert UG, Baczko K, Budka H, ter Meulen V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol. 1986; 67: 2435–2444
  • Liebert, UG, Schneider-Schaulies, S, Baczko, K, ter, M V 1990. Antibody-induced restriction of viral gene expression in measles encephalitis in rats J Virol. 64, 706–713.
  • Liljestrom P, Lusa S, Huylebroeck D, Garoff H. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol. 1991; 65: 4107–4113
  • Ludlow M, Duprex WP, Cosby SL, Allen IV, McQuaid S. Advantages of using recombinant measles viruses expressing a fluorescent reporter gene with vibratome slice technology in experimental measles neuropathogenesis. Neuropathol Appl Neurobiol 2008; 34: 424–34
  • Lulla V, Merits A, Sarin P, Kaariainen L, Keranen S, Ahola T. Identification of mutations causing temperature-sensitive defects in Semliki Forest virus RNA synthesis. J Virol. 2006; 80: 3108–3111
  • Lundstrom K, Abenavoli A, Malgaroli A, Ehrengruber MU. Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression. Mol Ther 2003; 7: 202–209
  • Oldstone MB, Buchmeier MJ. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 1982; 300: 360–362
  • Oliver KR, Scallan MF, Dyson H, Fazakerley JK. Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. J NeuroVirol. 1997; 3: 38–48
  • Pathak, S, Webb, HE 1983. Semliki Forest virus multiplication in oligodendrocytes in mouse- brain with reference to demyelination J. Physiol. (Lond), 339, 17.
  • Pusztai R, Gould E, Smith H. Infection pattern in mice of an avirulent and virulent strain of Semliki Forest virus. Br J Exp Pathol 1971; 52: 669–677
  • Ryan MD, King AM, Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol 1991; 72( Pt 11): 2727–2732
  • Salonen A, Vasiljeva L, Merits A, Magden J, Jokitalo E, Kaariainen L. Properly folded nonstructural polyprotein directs the semliki forest virus replication complex to the endosomal compartment. J Virol 2003; 77: 1691–1702
  • Scallan MF, Fazakerley JK. Aurothiolates enhance the replication of Semliki Forest virus in the CNS and the exocrine pancreas. J NeuroVirol 1999; 5: 392–400
  • Schoneboom BA, Fultz MJ, Miller TH, McKinney LC, Grieder FB. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. NeuroVirol. 1999; 5: 342–354
  • Sjoberg EM, Suomalainen M, Garoff H. A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Bio-Technology 1994; 12: 1127–1131
  • Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58: 491–562
  • Tamberg N, Lulla V, Fragkoudis R, Lulla A, Fazakerley JK, Merits A. Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol 2007; 88: 1225–1230
  • Tarbatt CJ, Glasgow GM, Mooney DA, Sheahan BJ, Atkins GJ. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. J Gen Virol 1997; 78: 1551–1557
  • Thomas JM, Klimstra WB, Ryman KD, Heidner HW. Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J Virol 2003; 77: 5598–5606
  • Tuittila M, Hinkkanen AE. Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence. J. Gen. Virol 2003; 84: 1525–1533

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.